146 related articles for article (PubMed ID: 16884284)
1. Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.
Shu CY; Zhang EY; Xiang JF; Zhu CF; Wang CR; Pei XL; Han HB
J Phys Chem B; 2006 Aug; 110(31):15597-601. PubMed ID: 16884284
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
Tóth E; Bolskar RD; Borel A; González G; Helm L; Merbach AE; Sitharaman B; Wilson LJ
J Am Chem Soc; 2005 Jan; 127(2):799-805. PubMed ID: 15643906
[TBL] [Abstract][Full Text] [Related]
3. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.
Bolskar RD; Benedetto AF; Husebo LO; Price RE; Jackson EF; Wallace S; Wilson LJ; Alford JM
J Am Chem Soc; 2003 May; 125(18):5471-8. PubMed ID: 12720461
[TBL] [Abstract][Full Text] [Related]
4. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
5. Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity.
Shu C; Corwin FD; Zhang J; Chen Z; Reid JE; Sun M; Xu W; Sim JH; Wang C; Fatouros PP; Esker AR; Gibson HW; Dorn HC
Bioconjug Chem; 2009 Jun; 20(6):1186-93. PubMed ID: 19445504
[TBL] [Abstract][Full Text] [Related]
6. Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH(2))](10).
Laus S; Sitharaman B; Tóth E; Bolskar RD; Helm L; Asokan S; Wong MS; Wilson LJ; Merbach AE
J Am Chem Soc; 2005 Jul; 127(26):9368-9. PubMed ID: 15984854
[TBL] [Abstract][Full Text] [Related]
7. Structural and relaxometric characterization of peptide aggregates containing gadolinium complexes as potential selective contrast agents in MRI.
Vaccaro M; Mangiapia G; Paduano L; Gianolio E; Accardo A; Tesauro D; Morelli G
Chemphyschem; 2007 Dec; 8(17):2526-38. PubMed ID: 17960748
[TBL] [Abstract][Full Text] [Related]
8. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
9. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of colloidal aqueous suspensions of a layered gadolinium hydroxide: a potential MRI contrast agent.
Lee BI; Lee KS; Lee JH; Lee IS; Byeon SH
Dalton Trans; 2009 Apr; (14):2490-5. PubMed ID: 19319394
[TBL] [Abstract][Full Text] [Related]
11. Ordering of lipid A-monophosphate clusters in aqueous solutions.
Faunce CA; Reichelt H; Quitschau P; Paradies HH
J Chem Phys; 2007 Sep; 127(11):115103. PubMed ID: 17887884
[TBL] [Abstract][Full Text] [Related]
12. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
[TBL] [Abstract][Full Text] [Related]
13. Gd3N@C84(OH)x: a new egg-shaped metallofullerene magnetic resonance imaging contrast agent.
Zhang J; Ye Y; Chen Y; Pregot C; Li T; Balasubramaniam S; Hobart DB; Zhang Y; Wi S; Davis RM; Madsen LA; Morris JR; LaConte SM; Yee GT; Dorn HC
J Am Chem Soc; 2014 Feb; 136(6):2630-6. PubMed ID: 24432974
[TBL] [Abstract][Full Text] [Related]
14. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
15. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents.
Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA
Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118
[TBL] [Abstract][Full Text] [Related]
16. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI.
Accardo A; Tesauro D; Roscigno P; Gianolio E; Paduano L; D'Errico G; Pedone C; Morelli G
J Am Chem Soc; 2004 Mar; 126(10):3097-107. PubMed ID: 15012139
[TBL] [Abstract][Full Text] [Related]
18. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
[TBL] [Abstract][Full Text] [Related]
19. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
